BDRX
Morgan Stanley’s Biodexa Pharmaceuticals BDRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-700
| Closed | -$924 | – | 8111 |
|
|
2025
Q1 | $924 | Buy |
+700
| New | +$924 | ﹤0.01% | 7290 |
|
|
2024
Q4 | – | Sell |
-14,320
| Closed | -$4.04K | – | 7977 |
|
|
2024
Q3 | $4.04K | Buy |
14,320
+14,304
| +89,400% | +$4.04K | ﹤0.01% | 6973 |
|
|
2024
Q2 | $14 | Hold |
16
| – | – | ﹤0.01% | 7767 |
|
|
2024
Q1 | $26 | Sell |
16
-16
| -50% | -$26 | ﹤0.01% | 7671 |
|
|
2023
Q4 | $86 | Buy |
32
+16
| +100% | +$43 | ﹤0.01% | 7506 |
|
|
2023
Q3 | $80 | Sell |
16
-1,352
| -99% | -$6.76K | ﹤0.01% | 7459 |
|
|
2023
Q2 | $94 | Hold |
1,368
| – | – | ﹤0.01% | 7500 |
|
|
2023
Q1 | $534 | Sell |
1,368
-14,328
| -91% | -$5.59K | ﹤0.01% | 7426 |
|
|
2022
Q4 | $15.5K | Buy |
15,696
+8,674
| +124% | +$8.54K | ﹤0.01% | 6783 |
|
|
2022
Q3 | $13K | Sell |
7,022
-75,422
| -91% | -$140K | ﹤0.01% | 6973 |
|
|
2022
Q2 | $45K | Sell |
82,444
-100,893
| -55% | -$55.1K | ﹤0.01% | 6660 |
|
|
2022
Q1 | $161K | Buy |
183,337
+36,190
| +25% | +$31.8K | ﹤0.01% | 6038 |
|
|
2021
Q4 | $155K | Sell |
147,147
-13,645
| -8% | -$14.4K | ﹤0.01% | 6191 |
|
|
2021
Q3 | $280K | Buy |
160,792
+18,278
| +13% | +$31.8K | ﹤0.01% | 5811 |
|
|
2021
Q2 | $296K | Buy |
142,514
+50,009
| +54% | +$104K | ﹤0.01% | 5816 |
|
|
2021
Q1 | $197K | Buy |
92,505
+73,719
| +392% | +$157K | ﹤0.01% | 5666 |
|
|
2020
Q4 | $35K | Sell |
18,786
-39,844
| -68% | -$74.2K | ﹤0.01% | 6265 |
|
|
2020
Q3 | $106K | Buy |
+58,630
| New | +$106K | ﹤0.01% | 5402 |
|
|
2019
Q4 | – | Sell |
-12,000
| Closed | -$15K | – | 6645 |
|
|
2019
Q3 | $15K | Sell |
12,000
-38,000
| -76% | -$47.5K | ﹤0.01% | 6085 |
|
|
2019
Q2 | $72K | Buy |
+50,000
| New | +$72K | ﹤0.01% | 5459 |
|
|
2016
Q2 | – | Sell |
-5
| Closed | – | – | 6508 |
|
|
2016
Q1 | $0 | Hold |
5
| – | – | ﹤0.01% | 6566 |
|
|
2015
Q4 | $0 | Buy |
+5
| New | – | ﹤0.01% | 6662 |
|